Childhood Cancer Awareness Month.
Fiscal committee
No
Current location
Chaptered
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates September of 2026 as Childhood Cancer Awareness Month in California. It acknowledges the significant impact of childhood cancer, highlighting the state’s leadership in treatment and research, including numerous specialized cancer centers and substantial funding for stem cell research. The resolution encourages statewide participation in awareness activities and expresses support for patients, families, and healthcare professionals involved in treating childhood cancer.
Key provisions
- Designates September 2026 as Childhood Cancer Awareness Month.
- Encourages participation in awareness activities and events.
- Recognizes California’s leadership in childhood cancer treatment and research.
- Acknowledges the significant progress in survival rates for children with cancer.
- Highlights the long-term side effects of cancer treatments in children.
- Supports efforts to find cures and less toxic treatments for childhood cancer.
- Expresses gratitude to healthcare professionals and families involved in pediatric cancer care.
- Recognizes the importance of advocacy by parents and families.
Who is affected
- Children and families affected by childhood cancer
- Healthcare professionals involved in pediatric cancer care
- California residents
- Organizations involved in cancer research and treatment
- Pediatric oncology teams
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
73 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours